HOLOGIC INC Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Hologic Inc quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q3 2017 to Q2 2024.
  • Hologic Inc Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending June 29, 2024 was $4.95B, a 4.46% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.95B -$231M -4.46% Jun 29, 2024 10-Q 2024-07-30
Q1 2024 $4.84B -$456M -8.61% Mar 30, 2024 10-Q 2024-07-30
Q4 2023 $4.65B -$439M -8.62% Dec 30, 2023 10-Q 2024-07-30
Q3 2023 $5.02B +$141M +2.89% Sep 30, 2023 10-Q 2024-07-30
Q2 2023 $5.18B +$184M +3.68% Jul 1, 2023 10-Q 2024-07-30
Q1 2023 $5.3B +$508M +10.6% Apr 1, 2023 10-Q 2024-07-30
Q4 2022 $5.09B +$573M +12.7% Dec 31, 2022 10-Q 2024-07-30
Q3 2022 $4.88B +$658M +15.6% Sep 24, 2022 10-Q 2024-07-30
Q2 2022 $5B +$1.12B +28.9% Jun 25, 2022 10-Q 2023-08-01
Q1 2022 $4.79B +$998M +26.3% Mar 26, 2022 10-Q 2023-08-01
Q4 2021 $4.52B +$1.25B +38.2% Dec 25, 2021 10-Q 2023-08-01
Q3 2021 $4.22B +$1.51B +55.8% Sep 25, 2021 10-K 2023-11-21
Q2 2021 $3.88B +$1.62B +71.7% Jun 26, 2021 10-Q 2022-07-27
Q1 2021 $3.8B +$1.7B +81.5% Mar 27, 2021 10-Q 2022-07-27
Q4 2020 $3.27B +$1.01B +44.8% Dec 26, 2020 10-Q 2022-07-27
Q3 2020 $2.71B +$592M +28% Sep 26, 2020 10-K 2023-11-21
Q2 2020 $2.26B Jun 27, 2020 10-Q 2021-07-28
Q1 2020 $2.09B Mar 28, 2020 10-Q 2021-07-28
Q4 2019 $2.26B Dec 28, 2019 10-Q 2021-07-28
Q3 2019 $2.12B -$313M -12.9% Sep 28, 2019 10-K 2022-11-15
Q3 2018 $2.43B -$356M -12.8% Sep 29, 2018 10-K 2021-11-16
Q3 2017 $2.78B Sep 30, 2017 10-K 2020-11-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.